Hemopressin is an inverse agonist of CB1 cannabinoid receptors (full – 2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2154475/
Novel endogenous peptide agonists of cannabinoid receptors (full – 2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2735371/
The Peptide Hemopressin Acts through CB1 Cannabinoid Receptors to Reduce Food Intake in Rats and Mice (full – 2010) http://www.jneurosci.org/content/30/21/7369.full
Binding of the hemopressin peptide to the cannabinoid CB1 receptor: structural insights. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/21062041
The effects of peptide and lipid endocannabinoids on arthritic pain at the spinal level. (full – 2012) http://journals.lww.com/anesthesiaan...inoids.30.aspx
Identification and quantification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB1 receptors. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481297/
Modulation of the cannabinoid receptors by hemopressin peptides. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594051/
Central functional response to the novel peptide cannabinoid, hemopressin. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23542442
Modulation of subventricular zone oligodendrogenesis: a role for hemopressin? (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936357/
Hemopressin, an inverse agonist of cannabinoid receptors, inhibits neuropathic pain in rats. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24703998
Analgesic tolerance and cross-tolerance to the cannabinoid receptors ligands hemopressin, VD-hemopressin(α) and WIN55,212-2 at the supraspinal level in mice. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25010019
Novel endogenous peptide agonists of cannabinoid receptors (full – 2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2735371/
The Peptide Hemopressin Acts through CB1 Cannabinoid Receptors to Reduce Food Intake in Rats and Mice (full – 2010) http://www.jneurosci.org/content/30/21/7369.full
Binding of the hemopressin peptide to the cannabinoid CB1 receptor: structural insights. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/21062041
The effects of peptide and lipid endocannabinoids on arthritic pain at the spinal level. (full – 2012) http://journals.lww.com/anesthesiaan...inoids.30.aspx
Identification and quantification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB1 receptors. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481297/
Modulation of the cannabinoid receptors by hemopressin peptides. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594051/
Central functional response to the novel peptide cannabinoid, hemopressin. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23542442
Modulation of subventricular zone oligodendrogenesis: a role for hemopressin? (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936357/
Hemopressin, an inverse agonist of cannabinoid receptors, inhibits neuropathic pain in rats. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24703998
Analgesic tolerance and cross-tolerance to the cannabinoid receptors ligands hemopressin, VD-hemopressin(α) and WIN55,212-2 at the supraspinal level in mice. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25010019